Use of peptides to selectively modulate CD4+ T-cell responses.
Hetzel
C
C
Department of Biology, Imperial College of Science, Technology and Medicine, London, U.K.
Janssen
R
R
Ely
S
S
Young
D
D
Lamb
J R
JR
Thole
J
J
D000818:Animals; D000941:Antigens / Q000008:administration & dosage / Q000627:therapeutic use*; D039741:Antigens, Dermatophagoides; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D017635:Clonal Anergy; D006023:Glycoproteins; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007073:Immunoglobulin E / Q000096:biosynthesis / Q000097:blood; D007167:Immunotherapy / Q000379:methods*; D008925:Mites / Q000276:immunology; D018448:Models, Immunological; D010446:Peptide Fragments / Q000008:administration & dosage / Q000627:therapeutic use*; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology
D000941:Antigens; D039741:Antigens, Dermatophagoides; D006023:Glycoproteins; D010446:Peptide Fragments; D007073:Immunoglobulin E